Request for Covid-19 Impact Assessment of this Report
End User/Technology
The most common forms of Aptamers areDNA, RNA and peptide aptamers.Aptamers discriminate between their targets with high precision and once selected, they bind to it with a strong bond. DNA and RNA aptamers are chosen from a wide range of nucleic acids and then optimized. This process is called SELEX.Once the target is found, the bonding happens by complementary RNA base-pairing.Secondary, structures like short helical arms and single-stranded loops are formed which combine the target to form tertiary structures and this bonding happens by van der Waals Forces hydrogen bonding and electrostatic interaction. DNA aptamers do not require reverse transcription, are stable and hence widely available compared to RNA aptamers.
Market Dynamics
Aptamers have a higher success rate of binding to large molecules as compared to antibodies, thanks to high investments in researchand development and latest technology. This has brought down costs and has led to the usage of aptamers in making new drugs and treatment of diseases. RNA aptamers have good diagnostic abilities and use in therapy. But, the aptamers are primarily sourced from animals. Stringent, regulations imposed by governments to reduce the use of animals for testing may prove to be a hindrance.Aptamers market is going to reach $8.91 billion in 2025 at a CAGR of 28.2%. Diseases like AIDS and Alzheimer's are driving the aptamers market
Market segmentation
Based on type:
--> Peptide
--> Nucleic Acid-based
Based on geography
--> Asia-Pacific
--> Europe
--> North America
--> Rest of The World
Based on industry
--> Diagnostics
--> Therapeutics
--> Research and Development
--> Others
Regional/Geographic Analysis
Aptamers market is going to reach $8.91 billion in 2025 at a CAGR of 28.2%.Globally, North America dominates the aptamers market because of favourable government policies and large investment in latest technology and R&D.In Europe, the aptamer technology is being used in small-scale industries and thus it had a market share of 35% globally which was second-largest after USGrowth, of aptamers in Asia-pacific is mainly due to diagnosis, therapy and manufacturing new drugs.The market was worth 24 million in 2016 and is predicted to become 66 million by 2021.
Key Players
--> AM Biotechnologies
--> Aptagen
--> Aptamer Sciences
--> BasePair Biotechnologies
--> Aptus Biotech
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...